专利号:EP-2173892-B8 优先权日:2007-07-27 标题:Process for the preparation of immobilised recombinant Penicillin Acylase biocatalyst from Achromobacter sp CCM 4824 expressed in E. coli BL21 CCM 7394 and its use for the synthesis of beta-lactam antiobiotics 发明人:DATLA ANUPAMA; RAJASEKAR VYASARAYANI WILLIAMS; KYSLIK PAVEL; BECKA STANISLAV; KRISHNAKANT ASHAR TRUPTI; YOGESH ZAMBRE SUJATA; NIKUNJ KUMAR 权利人:FERMENTA BIOTECH LTD 摘要:The present invention discloses isolation of Penicillin Acylase (PA) from Achromobacter sp CCM 4824 expressed in recombinant strain E. coli BL21 CCM 7394 bearing the recombinant plasmid pKXIP1 and processing of PA into biocatalyst useful for the industrial synthesis of antibiotics. More particularly the invention discloses a synthesis of semi-synthetic β-lactam antibiotics in the reaction mixture consisting of activated acyl-donor (D-p-hydroxyphenylglycine methyl ester or amide for Amoxicillin and Cefadroxil; D-phenylglycine methyl ester or amide for Ampicillin and Cephalexin) and nucleophile (6-APA or 7-ADCA) catalyzed by PA obtained from recombinant E. coli BL21 CCM 7394 as the biocatalyst.
专利号:WO-2011113486-A1 优先权日:2010-03-17 标 题 :Process for the synthesis of hydroxyphenylglycine esters 发明人:PALLARES BAYO ANTONIO; LOPEZ SANCHEZ RAMON; SANTIANDREU LOPEZ RICARDO MANUEL 权利人:DERETIL S A; PALLARES BAYO ANTONIO; LOPEZ SANCHEZ RAMON; SANTIANDREU LOPEZ RICARDO MANUEL 摘要:The present invention refers to a process for the synthesis of a D-(-)-p-hydroxyphenylglycine (HPG) ester in crystal form, by crystallizing D-HPG ester from a solution containing dissolved D-HPG ester to obtain a suspension comprising D-HPG ester crystals, characterized in that the ee D of the D-HPG ester in the solution and the ee D of the D-HPG ester crystals is above 95%, preferably above 97%, more preferably above 98%, more preferably above 99%, more preferably above 99.5%.
专利号:US-6156534-A 优先权日:1996-07-26 标 题:Synthesis of β-lactam antibacterials using soluble side chain esters and enzyme acylase 发明人:USHER JOHN J; ROMANCIK GUNA 权利人:BRISTOL MYERS SQUIBB CO 摘要:Disclosed is a process for the synthesis of β-lactam antibacterials using soluble side chain esters in the presence of enzyme acylase. Also disclosed are novel esters useful as reactants in said process.
专利号:US-2003044884-A1 优先权日:2000-10-11 标题:Synthesis of beta-lactam antibacterials using soluble side chain esters and enzyme acylase 发明人:USHER JOHN J; ROMANCIK GUNA 摘要:Disclosed is a process for the synthesis of β-lactam antibacterials using soluble side chain esters in the presence of enzyme acylase. Also disclosed are novel esters useful as reactants in said process.
专利号:US-2005186197-A1 优先权日:2002-08-29 标 题:Peptide inhibitors of beta lactamases 发明人:PALZKILL TIMOTHY; HUANG WANZHI 摘要:Peptide inhibitors of β-lactamases have been identified by the synthesis of peptide arrays using synthesis SPOT technology. These peptide inhibitors of β-lactamase have activity against a broad spectrum of β-lactamases and are useful in a variety of applications.
专利号:US-6218138-B1 优先权日:1998-05-26 标 题 :Synthesis of beta-lactam antibiotics with immobilized penicillin amidase 发明人:ILHAN FERHAT; KRAEMER DIETER 权利人:UNIFAR KIMYA SANAYI VE TICARET 摘要:Beta-lactam antibiotics are synthesized by reacting an amino-beta-lactam component with a corresponding amino-group-containing acylating side-chain component in the presence of penicillin amidase from E. coli covalently immobilized on support particles. The resulting beta-lactam antibiotic product is solubilized by adding an acid such as sulfuric acid to lower the pH to 1.0 at a temperature in the range of 0° C. to +5° C. The immobilized penicillin amidase is substantially inactivated by the acid. After separating the beta-lactam antibiotic product, the immobilized penicillin amidase is substantially reactivated for reuse in antibiotic synthesis by treatment with a buffer having about a neutral pH. Antibiotics that can be produced include ampicillin, amoxicillin, cephalexin, cefaclor and cefadroxil. Support particles that can be used include particles having a macroporous structure and a particle diameter of 10-1000 mum, particles having oxirane groups, particles made of a synthetic polymer and inorganic particles such as porous glass particles.
1: Kim EJ, Kim JE, Ro YS, Ko JY. Cefaclor-Induced Generalized Fixed Drug Eruption. Ann Dermatol. 2015 Aug;27(4):465-6. doi: 10.5021/ad.2015.27.4.465. Epub 2015 Jul 29. 2: Qian JQ, Correra TC, Li J, Maître P, Song DQ, Hu CQ. Differentiation of cefaclor and its delta-3 isomer by electrospray mass spectrometry, infrared multiple photon dissociation spectroscopy and theoretical calculations. J Mass Spectrom. 2015 Jan;50(1):265-9. doi: 10.1002/jms.3510. doi: 10.1002/cbic.201402268. Epub 2014 Oct 10. doi: 10.3349/ymj.2014.55.6.1473. 5: Huang C, Wang W, Miao L. Determination of cefaclor by UPLC-MS-MS for a Chinese pharmacokinetic study. J Chromatogr Sci. 2014 Aug;52(7):636-40. doi: 10.1093/chromsci/bmt092. Epub 2013 Jul 9. doi: 10.1107/S0108270113026863. Epub 2013 Oct 19. doi: 10.1007/s10661-012-2917-1. Epub 2012 Oct 7. doi: 10.1007/s00431-012-1926-y. Epub 2013 Jan 8. doi: 10.2478/acph-2013-0003. Italian. doi: 10.1055/s-0031-1298012. Epub 2012 Jan 27. doi: 10.1128/AAC.00263-10. Epub 2010 Aug 16.
合成参考文献
摘要:Drugs in Japan, -(552), 1990 摘要: 摘要:S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (2021) DOI:10.1021/acsenvironau.1c00008. List downloaded from 参考文献:10.1152/ajpgi.2001.281.3.g697 摘要:Groneberg DA, Döring F, Eynott PR, Fischer A, Daniel H. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2001 Sep 01;281(3):G697–704. doi: 10.1152/ajpgi.2001.281.3.g697.